It is noteworthy that HSPG2 is significantly highly expressed in CD34+ cells of AML patients, suggesting that perlecan is indeed secreted by the hematopoietic stem/progenitor cells in AML, even though that perlecan is known to be produced from mesenchymal stem cells37. This evidence concerns the gene HSPG2 and acute myeloid leukemia.